Skip to content

Doximity DOCS Return on equity

Return on equity at other companies

Microsoft logo
MicrosoftMSFT
34%+0.4pp
Veeva Systems logo
Veeva SystemsVEEV
13.9%-0.1pp
Solventum logo
SolventumSOLV
34.8%+24.1pp
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
16.9%
Cencora logo
CencoraCOR
130.6%-99.8pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-52.8%-12.7pp

Other financials

Income statement

See full
Revenue$145.4M+5.1%
Gross profit$126.0M+1.7%
Operating income$24.8M-49.0%
Net income$19.1M-69.4%
EPS (diluted)$0.10-67.7%

Balance sheet

See full
Cash & equivalents$219.2M+4.6%
Total debt$10.2M-17.8%
Total equity$950.8M-12.2%
Total assets$1.1B-11.1%

Cash flow

See full
Operating cash flow$109.5M+11.2%
CapEx-
Free cash flow$81.6M-17.1%

Valuation

See full
Market cap$3.74B-60.5%
Enterprise value$3.53B-61.7%
P/E19.1×-23.3×
P/S5.8×-10.8×

Profitability

See full
Gross margin89.1%-1.1pp
Operating margin33.3%-6.6pp
Net margin30.4%-8.7pp
FCF margin50.6%+2.7pp

Returns & leverage

See full
Debt / equity0.0×
Current ratio6.1×-0.9×

Where this comes from

Calculated from Doximity’s reported figures.

Based on trailing twelve months.

The official record: Doximity’s 10-K, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Doximity's return on equity?
Doximity (DOCS) reported return on equity of 19.3% in Q1 2026.
How has Doximity's return on equity changed year-over-year?
Doximity's return on equity decreased by 14.3% year-over-year, from 22.5% to 19.3%.
What is the long-term trend for Doximity's return on equity?
Over 5 years (2021 to 2026), Doximity's return on equity has grown at a -33.5% compound annual growth rate (CAGR), from 147.9% to 19.3%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.